Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ).
Guangzhou Baiyunshan Pharmaceutical Holdings Company has announced a disclosable transaction involving the disposal of accounts receivable by its subsidiary, GP Corp., to Industrial Securities Asset Management. This transaction, valued at approximately RMB501.96 million, is part of a series of similar transactions conducted within a 12-month period. The aggregate of these transactions exceeds a 5% but remains below a 25% threshold, thus requiring reporting and announcement under the Hong Kong Listing Rules, though it is exempt from shareholder approval. This move reflects the company’s strategic financial management and asset optimization efforts.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.50 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Average Trading Volume: 1,805,065
Technical Sentiment Signal: Buy
Current Market Cap: HK$46.22B
For an in-depth examination of 0874 stock, go to TipRanks’ Overview page.